From those IgM antibody-positive patients, 80% of RBD-positive patients had a SARS-CoV-2 infection less than 3 months before the antibody measurement, whereas 67% of RBD IgG-positive patients had an infection for more than 3 months (Figure 4a). This evidence concerns the gene CD40LG and infection.